BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23319424)

  • 1. Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status.
    Rizzato C; Kato I; Plummer M; Muñoz N; Stein A; Jan van Doorn L; Franceschi S; Canzian F
    Int J Cancer; 2013 Jul; 133(2):315-22. PubMed ID: 23319424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
    Plummer M; van Doorn LJ; Franceschi S; Kleter B; Canzian F; Vivas J; Lopez G; Colin D; Muñoz N; Kato I
    J Natl Cancer Inst; 2007 Sep; 99(17):1328-34. PubMed ID: 17728213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain.
    González CA; Figueiredo C; Lic CB; Ferreira RM; Pardo ML; Ruiz Liso JM; Alonso P; Sala N; Capella G; Sanz-Anquela JM
    Am J Gastroenterol; 2011 May; 106(5):867-74. PubMed ID: 21285949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions.
    Sicinschi LA; Correa P; Peek RM; Camargo MC; Piazuelo MB; Romero-Gallo J; Hobbs SS; Krishna U; Delgado A; Mera R; Bravo LE; Schneider BG
    Clin Microbiol Infect; 2010 Apr; 16(4):369-78. PubMed ID: 19456839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high-grade premalignant gastric lesions.
    Canzian F; Rizzato C; Obazee O; Stein A; Flores-Luna L; Camorlinga-Ponce M; Mendez-Tenorio A; Vivas J; Trujillo E; Jang H; Chen W; Kasamatsu E; Bravo MM; Torres J; Muñoz N; Kato I
    Int J Cancer; 2020 Nov; 147(9):2437-2445. PubMed ID: 32363734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobactor pylori cagA (+) infection.
    Yang GF; Deng CS; Xiong YY; Gong LL; Wang BC; Luo J
    World J Gastroenterol; 2004 Feb; 10(4):491-6. PubMed ID: 14966904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenic Helicobacter pylori in gastric pre-cancer and cancer lesions: association with tobacco-chewing.
    Pandey A; Tripathi SC; Mahata S; Vishnoi K; Shukla S; Misra SP; Misra V; Hedau S; Mehrotra R; Dwivedi M; Bharti AC
    World J Gastroenterol; 2014 Jun; 20(22):6860-8. PubMed ID: 24944476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between Helicobacter pylori infection and expression of connexin (Cx) 32 and Cx43 genes in gastric cancer and gastric precancerous lesions].
    Xu CX; Jia Y; Yang WB; Wang F; Shen SR
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1523-7. PubMed ID: 18956631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population.
    Pan KF; Formichella L; Zhang L; Zhang Y; Ma JL; Li ZX; Liu C; Wang YM; Goettner G; Ulm K; Classen M; You WC; Gerhard M
    Int J Cancer; 2014 May; 134(9):2118-25. PubMed ID: 24155048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of NFkappaB p65 and its target genes in gastric cancer and precancerous lesions].
    Yang GF; Deng CS; Xiong YY; Luo J; Wang BC; Tian SF; Xu K
    Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):551-3. PubMed ID: 15555287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
    Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
    J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in PSCA and risk of gastric advanced preneoplastic lesions and cancer in relation to Helicobacter pylori infection.
    Rizzato C; Kato I; Plummer M; Muñoz N; Canzian F
    PLoS One; 2013; 8(9):e73100. PubMed ID: 24023815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of
    Mera RM; Bravo LE; Camargo MC; Bravo JC; Delgado AG; Romero-Gallo J; Yepez MC; Realpe JL; Schneider BG; Morgan DR; Peek RM; Correa P; Wilson KT; Piazuelo MB
    Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphisms in myeloperoxidase and catalase genes with precancerous changes in the gastric mucosa of patients at inner-city hospitals in New York.
    Steenport M; Eom H; Uezu M; Schneller J; Gupta R; Mustafa Y; Villanueva R; Straus EW; Raffaniello RD
    Oncol Rep; 2007 Jul; 18(1):235-40. PubMed ID: 17549373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia.
    Zambon CF; Navaglia F; Basso D; Rugge M; Plebani M
    J Clin Pathol; 2003 Apr; 56(4):287-91. PubMed ID: 12663641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
    Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
    Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.
    Kudo M; Gutierrez O; El-Zimaity HM; Cardona H; Nurgalieva ZZ; Wu J; Graham DY
    J Clin Pathol; 2005 Mar; 58(3):259-62. PubMed ID: 15735156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori with stronger intensity of CagA phosphorylation lead to an increased risk of gastric intestinal metaplasia and cancer.
    Chuang CH; Yang HB; Sheu SM; Hung KH; Wu JJ; Cheng HC; Chang WL; Sheu BS
    BMC Microbiol; 2011 May; 11():121. PubMed ID: 21619658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer?
    Farinati F; Cardin R; Russo VM; Busatto G; Franco M; Rugge M
    Helicobacter; 2003 Jun; 8(3):227-34. PubMed ID: 12752735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.